Home>Topics>Companies>Orexigen Therapeutics

Orexigen Therapeutics

  1. All
  2. Commentary
  3. Headlines
  1. It Takes Less Than 15 Minutes To Buy VVUS Shares!

    Headlines

    Fri, 19 Sep 2014

    blockbuster potential in excess of a billion dollars per year. Qsymia will compete with Belviq by Arena (NASDAQ: ARNA ). Orexigen 's (NASDAQ: OREX ) drug was recently approved by the FDA, with the requirement for more safety trials like Qysimia. Discussion of the earnings

  2. Orexigen Therapeutics ( OREX ) Presents at Bank of America Merrill Lynch Global Healthcare Conference (Transcript)

    Headlines

    Thu, 18 Sep 2014

    By SA Transcripts : Orexigen Therapeutics , Inc . (NASDAQ: OREX ) Bank of America Merrill Lynch ..... s a pleasure for me to host Orexigen . Mark Booth, Chief Commercial ..... President of Takeda North America, Orexigen ’s current partner for their

  3. Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away

    Headlines

    Tue, 16 Sep 2014

    By Long Term Bio : Orexigen Therapeutics (NASDAQ: OREX ) received FDA approval for ..... help reduce their weight. Orexigen Therapeutics has been struggling to receive ..... The FDA had cited that Orexigen will need to run an additional

  4. Orexigen Falls After Approval - Why?

    Headlines

    Mon, 15 Sep 2014

    By Spencer Osborne : Orexigen (NASDAQ: OREX ) shares have tumbled upon FDA approval of the anti-obesity ..... sector has not performed like many thought it would. Prior to Orexigen getting FDA approval there were two other players in the space

  5. Arena And Vivus Ruined The FDA Approval Run Up For Orexigen

    Headlines

    Sat, 13 Sep 2014

    By R.S. Analytics : Orexigen 's (NASDAQ: OREX ) obesity drug, Contrave, finally received ..... approval last Thursday. Unfortunately for Orexigen longs, Arena Pharmaceutical's (NASDAQ ..... expectations with mediocre sales. So while Orexigen didn't enjoy much of a run-up into

  6. Orexigen : Poised To Grab A Large Part Of The Weight Loss Market

    Headlines

    Fri, 12 Sep 2014

    By Alexander Maxwell : Orexigen Therapeutics (NASDAQ: OREX ) investors were finally rewarded ..... after obtaining FDA approval for Orexigen 's weight-loss drug Contrave ..... the marketing of Contrave, Orexigen is partnered with Takeda Pharmaceuticals

  7. Belviq Advertising Sees Major Shift

    Headlines

    Fri, 12 Sep 2014

    aligned with the Labor Day weekend and preempted the announcement regarding the approval of a competing drug, Contrave, from Orexigen (NASDAQ: OREX ). During the week of September 1st through September 7th Belviq was advertised just 136 times but was in time slots that

  8. Orexigen Therapeutics' ( OREX ) CEO Mike Narachi Hosts Conference Call (Transcript)

    Headlines

    Thu, 11 Sep 2014

    By SA Transcripts : Orexigen Therapeutics , Inc . (NASDAQ: OREX ) Conference Call September 11, 2014 8:30 AM ..... Securities Presentation Operator Welcome to the Orexigen Therapeutics Conference Call. My name is Pellet and I will

  9. Orexigen's Contrave Approved: What It Means To Arena

    Headlines

    Thu, 11 Sep 2014

    By Spencer Osborne : Orexigen (NASDAQ: OREX ) received FDA approval for its anti-obesity drug Contrave on September 10, 2014. This is now the third "new" entrant into

  10. FDA Approves Orexigen's Contrave For Obesity Treatment

    Headlines

    Thu, 11 Sep 2014

    By Spencer Osborne : Orexigen (NASDAQ: OREX ) gained its anticipated approval of the anti-obesity drug Contrave. The announcement was made by the FDA after the market closed

« Prev1234Next »
Content Partners